Newsroom
Sorted by: Latest
-
Feinstein Institutes Finds Mitochondria Transplantation Dramatically Enhances Heart Recovery After Cardiac Arrest
MANHASSET, N.Y.--(BUSINESS WIRE)--With only approximately 10 percent of out-of-hospital cardiac arrest patients surviving, and many facing severe neurological or organ damage, a new study from Northwell Health’s Feinstein Institutes for Medical Research offers hope, revealing that mitochondria transplantation dramatically improves heart recovery and protects organs. Published as a letter to the editor in the American Journal of Respiratory and Critical Care Medicine (AJRCCM), this pivotal large...
-
Stonebranch est à nouveau désigné comme leader dans l'édition 2026 du Magic Quadrant® de Gartner™ consacré aux plateformes d'orchestration et d'automatisation des services (SOAP)
ALPHARETTA, Ga.--(BUSINESS WIRE)--Stonebranch, l’un des principaux fournisseurs de solutions d’orchestration et d’automatisation des services, a annoncé aujourd’hui avoir de nouveau été classé par Gartner parmi les Leaders du Magic Quadrant consacré aux plateformes d’orchestration et d’automatisation des services (SOAP) pour son offre, Universal Automation Center ™ (UAC).1 « Nous sommes ravis d’être reconnus comme “Leader” pour la troisième année consécutive », a déclaré Giuseppe Damiani, PDG d...
-
BeOne MedicinesとRevolution Medicines、臨床開発および地域別商業化に向けた提携を発表
米カリフォルニア州サンカルロスおよびカリフォルニア州レッドウッドシティ--(BUSINESS WIRE)--(ビジネスワイヤ) -- 腫瘍分野でグローバルに展開するBeOne Medicines(ナスダック:ONC、香港証券取引所:06160、上海証券取引所:688235、「BeOne」)とRAS依存性癌患者向けに後期臨床段階で腫瘍標的療法を開発するRevolution Medicines(ナスダック:RVMD)は、多岐にわたる提携を発表しました。この提携には、BeOneの特定の臨床段階にある腫瘍関連の薬剤資産と、Revolution Medicinesの4種類の臨床段階にあるRAS(ON)阻害剤との併用療法を評価する臨床提携、および特定のアジア市場におけるRevolution Medicinesの薬剤資産の独占的な開発・商業化権をBeOneに付与する地域別権利契約が含まれます。 この臨床提携は、RAS依存性癌患者を対象とした標的併用療法のアプローチの可能性を模索 臨床提携の一環として開発が検討される併用療法の候補には、BeOneの特定の薬剤候補と、Revolution Medici...
-
BeOne Medicines e Revolution Medicines anunciam cooperação para desenvolvimento clínico e comercialização regional
SAN CARLOS, Califórnia e REDWOOD CITY, Califórnia--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), uma empresa multinacional de oncologia, e Revolution Medicines, Inc. (Nasdaq: RVMD), Uma empresa de oncologia clínica em estágio avançado que desenvolve terapias direcionadas a pacientes com tipos de câncer que dependem de RAS anunciou hoje uma cooperação de múltiplas etapas, incluindo: uma cooperação clínica para avaliar combinações de medicamentos que incorporem at...
-
BeOne Medicines y Revolution Medicines anuncian una colaboración para el desarrollo clínico y la comercialización en determinados mercados asiáticos
SAN CARLOS, California, y REDWOOD CITY, California--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), una empresa global especializada en oncología, y Revolution Medicines, Inc. (Nasdaq: RVMD), una empresa biofarmacéutica en fase clínica avanzada que desarrolla terapias dirigidas para pacientes con cánceres dependientes de RAS, anunciaron hoy una colaboración que comprende dos acuerdos. El primero es una colaboración clínica para evaluar combinaciones de determinado...
-
KBRA Assigns Preliminary Ratings to Morgan Stanley Residential Mortgage Loan Trust 2026-NEW2 (MSRM 2026-NEW2)
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage-backed certificates from Morgan Stanley Residential Mortgage Loan Trust 2026-NEW2 (MSRM 2026-NEW2). MSRM 2026-NEW2 is an RMBS transaction sponsored by Morgan Stanley Mortgage Capital Holdings LLC as seller/sponsor and includes a meaningful concentration of collateral that KBRA considers to be “non-prime.” The $418.1 million RMBS transaction is collateralized by a pool of 670 fixed-rate residential mortgages....
-
CORRECTING and REPLACING Avaya Aura® 10.3 Gives Enterprises a Secure, Long-Term Path to Modernize
MORRISTOWN, N.J.--(BUSINESS WIRE)--Avaya today announced Avaya Aura® 10.3, the latest release of its enterprise voice and unified communications platform....
-
Memphis Tradition of Hope Continues to Change Children's Lives During the 2026 FedEx St. Jude Championship Benefiting St. Jude Children's Research Hospital®
MEMPHIS, Tenn.--(BUSINESS WIRE)--As 70 of the world's best golfers descend on Memphis for the 2026 FedEx St. Jude Championship, patients from St. Jude Children’s Research Hospital® will once again be at the heart of tournament week, showcasing the powerful impact of the supporters, partners and communities helping advance its lifesaving mission. The 2026 FedEx St. Jude Championship, Aug. 13-16 at TPC Southwind, brings together the top players in the FedExCup standings while continuing a decades...
-
BWMN Investors Have Opportunity to Join Bowman Consulting Group Ltd. Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)--BWMN Investors Have Opportunity to Join Bowman Consulting Group Ltd. Fraud Investigation with SBS Law...
-
Greycourt Completes Ownership Succession Plan, Bolstering Independence and Client Alignment
PITTSBURGH--(BUSINESS WIRE)--Greycourt LLC, one of the nation's leading investment advisors to ultra-high net worth clients, today announced it has completed a management-led transition of the firm’s ownership, cementing its long-held culture of independence, creativity, and expertise. Greycourt is now entirely owned and controlled by employees and has activated an equity rotation plan designed to maintain this structure in perpetuity. The next generation of the firm's leadership purchased all...